日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors

一项评估 TLR9 激动剂 cavrotolimod 与抗 PD-1 抗体联合治疗晚期实体瘤患者的安全性、有效性和免疫效应的 1b/2 期研究

Milhem, Mohammed M; Wise-Draper, Trisha M; Chandra, Sunandana; Hanna, Glenn J; Laux, Douglas E; Medina, Theresa M; Ansstas, George; Daud, Adil; Kelly, Ciara M; O'Day, Steven J; Perez, Cesar A; Wong, Michael K; Friedlander, Philip A; Kristedja, Timothy S; Burgess, Melissa A; Cowey, C Lance; Hanks, Brent A; Weight, Ryan M; Daniel, Weston L; Feltner, Douglas E; Mix, Scott; Sindelar, Laurel; Bexon, Alice S; Bexon, Martin F; Michel, Robert E; Bhatia, Shailender

CVN424, a GPR6 inverse agonist, for Parkinson's disease and motor fluctuations: a double-blind, randomized, phase 2 trial

CVN424(一种 GPR6 反向激动剂)用于治疗帕金森病和运动波动:一项双盲、随机、II 期试验

Brice, Nicola L; Carlton, Mark; Margolin, David H; Bexon, Martin; Matthews, Kim L; Dawson, Lee A; Ellenbogen, Aaron L; Olanow, C Warren; Dubow, Jordan; Kieburtz, Karl

Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-Enhanced Delivery of IL4R-Targeted Immunotoxin MDNA55 in Recurrent Glioblastoma

改良型RANO、免疫疗法RANO和标准RANO对IL4R靶向免疫毒素MDNA55对复发性胶质母细胞瘤的对流增强递送的反应

Ellingson, Benjamin M; Sampson, John; Achrol, Achal Singh; Aghi, Manish K; Bankiewicz, Krystof; Wang, Chencai; Bexon, Martin; Brem, Steven; Brenner, Andrew; Chowdhary, Sajeel; Floyd, John R; Han, Seunggu; Kesari, Santosh; Randazzo, Dina; Vogelbaum, Michael A; Vrionis, Frank; Zabek, Miroslaw; Butowski, Nicholas; Coello, Melissa; Merchant, Nina; Merchant, Fahar

IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers

IMMUNO-COV v2.0:用于测量 SARS-CoV-2 中和抗体滴度的高通量临床检测方法的开发和验证

Rianna Vandergaast, Timothy Carey, Samantha Reiter, Chase Lathrum, Patrycja Lech, Clement Gnanadurai, Michelle Haselton, Jason Buehler, Riya Narjari, Luke Schnebeck, Anne Roesler, Kara Sevola, Lukkana Suksanpaisan, Alice Bexon, Shruthi Naik, Bethany Brunton, Scott C Weaver, Grace Rafael, Sheryl Tran

Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2

IMMUNO-COV™ 的开发和验证:一种用于检测中和 SARS-CoV-2 抗体的高通量临床检测方法

Vandergaast, Rianna; Carey, Timothy; Reiter, Samantha; Lech, Patrycja; Gnanadurai, Clement; Tesfay, Mulu; Buehler, Jason; Suksanpaisan, Lukkana; Naik, Shruthi; Brunton, Bethany; Recker, Jordan; Haselton, Michelle; Ziegler, Christopher; Roesler, Anne; Mills, John R; Theel, Elitza; Weaver, Scott C; Rafael, Grace; Roforth, Matthew M; Jerde, Calvin; Tran, Sheryl; Diaz, Rosa Maria; Bexon, Alice; Baum, Alina; Kyratsous, Christos A; Peng, Kah Whye; Russell, Stephen J

Oncolytic Measles Virotherapy and Opposition to Measles Vaccination

溶瘤麻疹病毒疗法与反对麻疹疫苗接种

Russell, Stephen J; Babovic-Vuksanovic, Dusica; Bexon, Alice; Cattaneo, Roberto; Dingli, David; Dispenzieri, Angela; Deyle, David R; Federspiel, Mark J; Fielding, Adele; Galanis, Eva; Lacy, Martha Q; Leibovich, Bradley C; Liu, Minetta C; Muñoz-Alía, Miguel; Miest, Tanner C; Molina, Julian R; Mueller, Sabine; Okuno, Scott H; Packiriswamy, Nandakumar; Peikert, Tobias; Raffel, Corey; Van Rhee, Frits; Ungerechts, Guy; Young, Paul R; Zhou, Yumei; Peng, Kah-Whye

Novel inflammatory cell infiltration scoring system to investigate healthy and footrot affected ovine interdigital skin

一种用于研究健康绵羊和患有蹄腐病的绵羊趾间皮肤的新型炎症细胞浸润评分系统

Agbaje, Michael; Rutland, Catrin S; Maboni, Grazieli; Blanchard, Adam; Bexon, Melissa; Stewart, Ceri; Jones, Michael A; Totemeyer, Sabine

Efficacy and safety of IgPro20, a subcutaneous immunoglobulin, in Japanese patients with primary immunodeficiency diseases

皮下注射免疫球蛋白IgPro20治疗日本原发性免疫缺陷病患者的疗效和安全性

Kanegane, Hirokazu; Imai, Kohsuke; Yamada, Masafumi; Takada, Hidetoshi; Ariga, Tadashi; Bexon, Martin; Rojavin, Mikhail; Hu, Wilson; Kobayashi, Midori; Lawo, John-Philip; Nonoyama, Shigeaki; Hara, Toshiro; Miyawaki, Toshio

Higher doses of subcutaneous IgG reduce resource utilization in patients with primary immunodeficiency

较高剂量的皮下注射IgG可减少原发性免疫缺陷患者的资源消耗。

Haddad, Elie; Berger, Melvin; Wang, Edward C Y; Jones, Christopher A; Bexon, Martin; Baggish, Jeffrey S

Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics

预测肝肾综合征(HRS)1型患者对特利加压素联合白蛋白治疗反应的因素:血清肌酐与血流动力学的关系

Boyer, Thomas D; Sanyal, Arun J; Garcia-Tsao, Guadalupe; Blei, Andres; Carl, Daniel; Bexon, Alice S; Teuber, Peter